NCT07444697

Brief Summary

The goal of this observational study is to assess changes in patients' erectile function after percutaneous coronary intervention (PCI) using a standard IIEF (International Index of Erectile Function) questionnaire at 1, 3, and 6 months post-PCI. By doing this, we try to compare patients' responses to PCI after having a heart attack and stable angina to see the real effect of myocardial infarction on erectile function status in the long term by comparing it with a very similar group.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
3mo left

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Jan 2026Nov 2026

Study Start

First participant enrolled

January 15, 2026

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

January 20, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 3, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

March 3, 2026

Status Verified

February 1, 2026

Enrollment Period

10 months

First QC Date

January 20, 2026

Last Update Submit

February 24, 2026

Conditions

Keywords

erectile disfunctioncoronary artery diseaseSyntax scorepercutaneous coronary interventionanxietyFearangina

Outcome Measures

Primary Outcomes (1)

  • Change in erectile function score after percutaneous coronary intervention (PCI)

    Description: Erectile function will be assessed using the International Index of Erectile Function-5 (IIEF-5) questionnaire. The primary outcome is the change in mean IIEF-5 score from baseline to 6 months after PCI, comparing patients with myocardial infarction (Group 1) and those with stable angina (Group 2). A decrease in IIEF-5 score indicates worsening erectile function.

    Baseline (post-recovery from PCI) to 6 months follow-up]

Secondary Outcomes (3)

  • Effect of myocardial infarction on post-PCI erectile function

    Baseline (post-PCI recovery) and 6 months after PCI

  • Effect of myocardial infarction on post-PCI erectile function

    Baseline (post-PCI recovery) and 6 months after PCI

  • Association between fear symptoms and post-PCI erectile function Fear symptoms will be assessed using the Beck Depression Inventory (BDI), and their association with erectile function measured by the IIEF-5 will be examined.

    Baseline, 3 months, and 6 months after PCI

Other Outcomes (3)

  • Correlation between SYNTAX score (angiographic coronary disease burden, points) and erectile function score measured by IIEF-5 (points)

    Baseline (post-PCI recovery) and 6 months after PCI

  • Correlation between Beck Depression Inventory (BDI) score (points) and erectile function score measured by IIEF-5 (points)

    Baseline, 3 months, and 6 months after PCI

  • Correlation between composite demographic-procedural risk score (points) and change in IIEF-5 score (points)

    Baseline to 6 months follow-up

Study Arms (2)

Group 1

Patients who undergo PCI due to a heart attack

Group 2

Patients who undergo PCI due to a stabile angina

Eligibility Criteria

Age30 Years - 75 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMale gender is suitable for the study due to evalute the penile erectile status
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will consist of adult male patients treated with percutaneous coronary intervention (PCI) for either acute myocardial infarction or stable angina at the Cardiology Department of Kırıkkale University Hospital. Eligible participants will be recruited consecutively after successful PCI and clinical stabilization. The study represents a hospital-based, observational cohort reflecting the typical male population undergoing PCI in a tertiary referral center. All assessments and follow-up visits will be conducted within the same institution's cardiology and urology outpatient clinics.

You may qualify if:

  • Male patients aged 30-75 years
  • Undergoing successful percutaneous coronary intervention (PCI) for one of the following:
  • Acute myocardial infarction (Group 1)
  • Stable angina (Group 2)
  • Hemodynamically stable after the PCI procedure
  • Survival of the index hospitalization
  • Ability to provide written informed consent
  • Sexually active within the 3 months prior to enrollment
  • Willingness and ability to complete follow-up visits and questionnaires at:
  • Baseline (post-PCI recovery)
  • months

You may not qualify if:

  • Known malignancy (active or recently treated)
  • Neurological disorders affecting erectile function, including:
  • Spinal cord injury
  • Multiple sclerosis
  • Parkinson's disease
  • Uncontrolled diabetes mellitus (HbA1c \> 9%)
  • Presence of more than two chronic systemic diseases, such as:
  • Severe renal disease
  • Severe hepatic disease
  • Severe pulmonary disease
  • Polypharmacy, defined as chronic use of more than three daily medications
  • Absence of sexual activity or lack of a sexual partner
  • Refusal or inability to provide informed consent or complete study questionnaires
  • Severe psychiatric illness interfering with study participation
  • Endocrine disorders, including:
  • +6 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hospital of Kirikkale Univerity Faculty of Medicine

Kırıkkale, 71450, Turkey (Türkiye)

RECRUITING

Related Publications (7)

  • Dostalova G, Hlubocka Z, Bayerova K, Belohlavek J, Linhart A, Karetova D. Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up. Am J Mens Health. 2017 Nov;11(6):1739-1744. doi: 10.1177/1557988317714359. Epub 2017 Jul 11.

  • Hodzic E, Durek A, Begic E, Sabanovic Bajramovic N. Effect of myocardial infarction on the occurrence of erectile dysfunction. Med Glas (Zenica). 2019 Feb 1;16(1):35-39. doi: 10.17392/981-19.

  • Adam A, McDowall J, Aigbodion SJ, Enyuma C, Buchanan S, Vachiat A, Sheahan J, Laher AE. Is the History of Erectile Dysfunction a Reliable Risk Factor for New Onset Acute Myocardial Infarction? A Systematic Review and Meta-Analysis. Curr Urol. 2020 Oct;14(3):122-129. doi: 10.1159/000499249. Epub 2020 Oct 13.

  • Clarke ST, Le Grande M, Murphy BM, Hester R, Jackson AC. Protocol for the development and validation of a clinical measurement tool for fear of disease progression and recurrence in cardiac patients. Chronic Dis Transl Med. 2024 Jan 24;10(3):195-204. doi: 10.1002/cdt3.115. eCollection 2024 Sep.

  • Vacanti L, Caramelli B. Distress: associated variables of erectile dysfunction post-acute myocardial infarction. A pilot study. Int J Impot Res. 2005 Mar-Apr;17(2):204-6. doi: 10.1038/sj.ijir.3901274.

  • Montorsi P, Ravagnani PM, Galli S, Salonia A, Briganti A, Werba JP, Montorsi F. Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient. Eur Urol. 2006 Oct;50(4):721-31. doi: 10.1016/j.eururo.2006.07.015. Epub 2006 Jul 28.

  • Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O'Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE; COURAGE Trial Research Group; Mancini GB. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008 Aug 14;359(7):677-87. doi: 10.1056/NEJMoa072771.

MeSH Terms

Conditions

Coronary Artery DiseaseDiabetes MellitusAnxiety DisordersDepressionAngina Pectoris

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesMental DisordersBehavioral SymptomsBehaviorChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Timucin Sipal, Assistan Prof

    Kirikkale Univerity faculty of medicine department of Urology

    PRINCIPAL INVESTIGATOR
  • Caglar Alp, Assistant Prof

    Kirikkale Univerity Faculty of Medicine department of Cardiology

    STUDY DIRECTOR

Central Study Contacts

Timucin Sipal, MD, PhD

CONTACT

Caglar Alp, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistan profesor

Study Record Dates

First Submitted

January 20, 2026

First Posted

March 3, 2026

Study Start

January 15, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

March 3, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to privacy considerations.

Locations